Bullish option flow detected in Iovance Biotherapeutics with 3,849 calls trading, 1.0x expected, and implied vol increasing almost 12 points to 83.09%. Oct-24 11 calls and Sep-24 13 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.09. Earnings are expected on November 5th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Biotech Alert: Searches spiking for these stocks today
- Iovance Biotherapeutics price target lowered to $24 from $26 at Baird
- Iovance Biotherapeutics reports Q2 EPS (34c), consensus (35c)
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024